First-line single agent treatment with gefitinib in patients with advanced non-small-cell lung cancer

Lignende værker

• Gefitinib for the first-line treatment of locally advanced or metastatic non-small cell lung cancer
  af: T Brown, et al.
  Udgivet: (2010-10-01)
• Fruquintinib with gefitinib as first-line therapy in patients carrying EGFR mutations with advanced non-small cell lung cancer: a single-arm, phase II study
  af: Lu, Shun, et al.
  Udgivet: (2021)
• A phase II study of single-agent gefitinib as first-line therapy in patients with stage IV non-small-cell lung cancer
  af: Suzuki, R, et al.
  Udgivet: (2006)
• Comparison of single-agent chemotherapy and targeted therapy to first-line treatment in patients aged 80 years and older with advanced non-small-cell lung cancer
  af: Zhang, Qianqian, et al.
  Udgivet: (2015)
• Cost-Effectiveness Analysis of Dacomitinib versus Gefitinib in the First-Line Treatment of EGFR-Positive Advanced or Metastatic Non-Small Cell Lung Cancer
  af: Zhang, Longfeng, et al.
  Udgivet: (2021)